Deutsche Bank estimates the impact of rising interest rates: US major banks face capital pressure, and stock buybacks may collectively hit the brakes.
Deutsche Bank recently released an industry research report focusing on the capital pressure faced by large US banks amid a significant rise in interest rates expected in Q3 2026.
According to Smart Finance APP, Deutsche Bank recently released an industry research report focusing on the capital pressures facing large U.S. banks against the backdrop of a significant interest rate increase expected in the third quarter of 2026. The report uses two sets of calculation models to assess the impact of interest rate fluctuations on Core Tier 1 Capital (CET1) through Accumulated Other Comprehensive Income (AOCI), and analyzes the evolution of bank stock buyback policies.
In a previous third-quarter performance outlook report, Deutsche Bank estimated that rising interest rates would put an average pressure of 51 basis points on the book capital of banks covering AOCI adjustments. To refine the calculation logic, the report introduces a second estimation method: instead of measuring only the gains and losses of Available-for-Sale securities (AFS), it applies the actual change in AOCI during the first half of 2026, a period of rising rates, and multiplies this by a factor of three (reflecting that the third-quarter rate increase is about three times that of the first half) to extrapolate capital losses for the third quarter. Both methods yield roughly similar average capital impact results across the industry, but there are significant differences in the results for individual banks.
Under the new model, capital pressure for investment banks (Goldman Sachs, Morgan Stanley), JPMorgan, Bank of America, and Wells Fargo is lower compared to the old model, with the largest adjustments seen for Morgan Stanley and Wells Fargo. For large regional banks, the overall average impact differs by only 2 basis points, but there is clear internal divergence: capital pressure eased noticeably for CFG, FITB, and USB, while capital losses were actually higher for MTB, RF, and TFC.
Banks may slow down or pause stock buybacks until rates stabilize
Although the capital calculations show that each bank’s absolute capital levels still meet regulatory requirements, the rapid rise in interest rates, highly uncertain rate outlook, and strong loan growth lead Deutsche Bank to judge that most banks will slow down or even pause stock buybacks. To restart buybacks and recover to mid-single-digit levels, banks will need to wait for rates to stabilize. Over the long term, if regulatory capital rules are implemented and the Federal Reserve’s annual stress tests are moderately relaxed with improved transparency, the scale of buybacks could rise further.
The banking group is expected to diverge: monetary center banks such as JPMorgan, Bank of America, and Wells Fargo will slow their pace of buybacks but not completely stop. This judgment is based on their solid capital base and strong profit generation as of the end of June, alongside an ongoing need to expand corporate and consumer lending and serve institutional client trading and financing needs.
In contrast, among large regional banks, 7 out of the 9 sampled by Deutsche Bank are likely to pause buybacks, as their simulated capital (after accounting for AOCI impact) is at or below 9.0%. Among them, MTB has sufficient capital buffer and may maintain buybacks; USB’s capital is close to the threshold and remains under greater capital constraints as it continues to expand its business and adjust bank category.
The report also discusses the much-debated issue of asset valuation: currently, only systemically important large banks include AOCI in regulatory capital, but future regulatory rules may expand its scope; unrealized losses on Held-to-Maturity securities (HTM) are not factored into regulatory or rating agency capital adjustments, but are considered by market investors; and low-cost deposit liabilities are not marked to market, but these liabilities have real value in a high-rate environment.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
BUZZ - Delta Air Lines shares fall after lowering full-year profit guidance
October 9 - Delta Air Lines (DAL.N) shares fell nearly 5% in pre-market trading to $78.12. Due to a surge in jet fuel prices, Delta Air Lines (DAL) on Friday lowered its full-year adjusted profit forecast. The U.S. airline now expects adjusted earnings per share in 2026 to be between $5.10 and $5.60, down from the previous guidance of $6.5 to $7.5 per share. The current midpoint of $5.35 per share is lower than analysts’ expectations of $5.46 per share. DAL expects its annual fuel costs to rise by about $6.0 billion, compared to an earlier projection of a $4.0 billion increase. Analysts tracking DAL have given it an average “Buy” rating, according to data compiled by LSEG. So far this year, Delta Air Lines stock has risen 18.4%, the highest increase among major U.S. competitors. (For the convenience of non-English speakers, Reuters automatically translates its reports into several other languages. Since automated translations may contain errors or lack the necessary context, Reuters does not guarantee the accuracy of automated translation texts, which are provided solely for readers’ convenience. Reuters assumes no responsibility for any damage or loss resulting from the use of automated translation services.)
Strategy shareholders face dilution drag despite brighter bitcoin forecasts, TD Cowen says
BUZZ-TD Cowen lowers its target price for UnitedHealth Group ahead of third-quarter earnings release
On October 9, TD Cowen lowered its price target for UnitedHealth Group (UNH.N) from $430 to $402 ahead of the company's third-quarter earnings report on October 13. The brokerage stated that the widely expected third-quarter medical cost ratio of 89.9% and earnings per share of $4.12 are "well within reach." The report pointed out that recently announced Medicare star ratings have fallen as anticipated, which is expected to create a $1.5 billion revenue headwind in 2028. The new price target represents a 6.9% upside from the stock's previous closing price. "We also expect management to comment on preliminary expectations for 2027 Medicare Advantage (MA) enrollment growth and may emphasize a focus on margins over enrollment growth," the brokerage added. Earnings forecasts remain unchanged, but a lowered valuation multiple led to the reduction in price target. Among 29 brokerages, 23 rate the stock a "buy" or higher, while 6 rate it "hold"; the median price target is $483.82, according to LSEG data. As of the previous close, the stock is up 12.3% year-to-date.
